ENvue Medical today unveiled ENvue Drive, its next-generation robotic-assisted tool for real-time guided bedside feeding tube placement.
Tyler, Texas-based ENvue Medical — formerly NanoVibronix — said it represents the first next-generation robotic-assisted tool built within the ENvue electromagnetic navigation platform ecosystem. It designed the technology to integrate AI, real-time navigation and robotic-assisted procedural execution into a unified clinical workflow.
ENvue Medical said its unveiling marks the successful development and demonstration of the prototype for ENvue Drive. It integrates proprietary Ask Oscar AI navigation software with robotic-assisted tube advancement. This replicates a bedside enteral access procedure.
The company said its demonstration showcased the ability to identify anatomical pathways, detect trajectory deviations, provide corrective guidance, and assist in advancing to a target position within the small intestine under clinician supervision.
ENvue Medical designed the technology to assist, not replace the clinician, who retains complete control of the procedure.
The company built its platform on the FDA-cleared ENvue Navigation Platform, currently used in hospitals across the U.S. Its existing platform provides real-time electromagnetic guidance during enteral feeding tube placement. Ask Oscar technology offers AI-based education and training, with its architecture now geared toward future procedural guidance and robotic-assisted execution.
“For decades, bedside medicine has relied on training, experience, and manual execution. We believe the next major advance will come from combining navigation, intelligence, and automation into a unified platform that assists clinicians throughout the procedure,” said Dr. Doron Besser, Chief Executive Officer, ENvue Medical. “We believe ENvue Drive represents an important step toward that future.”
